Meeting
2012 Genitourinary Cancers Symposium
Use of elevated insulin-like growth factor binding protein-1 (IGFBP-1) to predict outcomes in men with metastatic prostate cancer treated with androgen-deprivation therapy (ADT).
Authors
Jaya Sharma
Dana-Farber Cancer Institute, Boston, MA
Jaya Sharma , Kathryn P. Gray , Mari Nakabayashi , Gillian Petrozziello , Carolyn Evan , Raina Fichorova , Philip W. Kantoff , Christopher Sweeney
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session C: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer
Citation
J Clin Oncol 30, 2012 (suppl 5; abstr 191)
DOI
10.1200/jco.2012.30.5_suppl.191
Abstract #
191
Poster Bd #
B11
Abstract Disclosures
Similar Posters
Poster
2022 ASCO Annual Meeting
DynAMo: A dynamic allocation modular sequential trial of approved and promising therapies in men with metastatic CRPC.
First Author: Paul Vincent Viscuse
Poster
2020 Genitourinary Cancers Symposium
Gene expression in circulating tumor cells (CTC) and plasma androgen receptor (AR) gene copy number (CN) for castration-resistant prostate cancer (CRPC) patients (pts) treated with cabazitaxel.
First Author: Giorgia Gurioli
Poster
2017 ASCO Annual Meeting
A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors.
First Author: Amikar Sehdev
Poster
2016 ASCO Annual Meeting
Genome-wide association study (GWAS) of response to androgen deprivation therapy (ADT) and survival in metastatic prostate cancer (PCa).
First Author: Mark Pomerantz